Abstract:Background The head-twitch response (HTR) in mice is considered a behavioral model for hallucinogens and serotonin 5-HT 2A receptor function, as well as Tourette syndrome in humans. It is mediated by 5-HT 2A receptor agonists such as ( ±)− 2,5-dimethoxy-4-iodoamphetamine (DOI) in the prefrontal cortex (PFC). The 5-HT 2A antagonist EMD 281014, can prevent both DOI-induced HTR during ageing and c-fos expression in different regions of PFC. Moreover, the nonselective monoamine releaser methamphetamine (MA) suppressed DOI-induced HTR through ageing via concomitant activation of inhibitory 5-HT 1A receptors, but enhanced DOI-evoked c-fos expression. d -Fenfluramine is a selective 5-HT releaser and induces HTR in mice, whereas MA does not. Currently, we investigated whether EMD 281014 or MA would alter: (1) d -fenfluramine-induced HTR frequency in 20-, 30- and 60-day old mice, (2) d -fenfluramine-evoked c- fos expression in PFC, and (3) whether blockade of inhibitory serotonergic 5-HT 1A - or adrenergic ɑ 2 -receptors would prevent suppressive effect of MA on d -fenfluramine-induced HTR. Results EMD 281014 (0.001–0.05 mg/kg) or MA (0.1–5 mg/kg) blocked d -fenfluramine-induced HTR dose-dependently during ageing. The 5-HT 1A antagonist WAY 100635 countered the inhibitory effect of MA on d -fenfluramine-induced HTR in 30-day old mice, whereas the adrenergic ɑ 2 antagonist RS 79948 reversed MA’s inhibitory effect in both 20- and 30- day old mice. d -Fenfluramine significantly increased c- fos expressions in PFC regions. MA (1 mg/kg) pretreatment significantly increased d -fenfluramine-evoked c- fos expression in different regions of PFC. EMD 281014 (0.05 mg/kg) failed to prevent d -fenfluramine-induced c- fos expression, but significantly increased it in one PFC region (PrL at − 2.68 mm). Conclusion EMD 281014 suppressed d -fenfluramine-induced HTR but failed to prevent d -fenfluramine-evoked c- fos expression which suggest involvement of additional serotonergic receptors in the mediation of evoked c- fos . The suppressive effect of MA on d -fenfluramine-evoked HTR is due to well-recognized functional interactions between stimulatory 5-HT 2A - and the inhibitory 5-HT 1A - and ɑ 2 -receptors. MA-evoked increases in c- fos expression in PFC regions are due to the activation of diverse monoaminergic receptors through increased synaptic concentrations of 5-HT, NE and/or DA, which may also account for the additive effect of MA on d -fenfluramine-evoked changes in c- fos expression. Our findings suggest potential drug receptor functional interaction during development when used in combination.

Dextromethorphan moderates reward deficiency associated with central serotonin transporter availability in 3,4-methylenedioxy-methamphetamine-treated animals

Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats

5-HT2C receptors in the nucleus accumbens constrain the rewarding effects of MDMA

Effects of Dextromethorphan on Nicotine-Induced Reward, Behavioral Sensitization, Withdrawal Signs, and Drug Seeking-Related Behavior in Rats

Constrasting Effects of Dopaminergic Blockade on MDMA and D-Amphetamine Conditioned Taste Aversions

The Distinct Roles of Various Neurotransmitters in Modulating Methamphetamine-Induced Conditioned Place Preference in Relevant Brain Regions in Mice

Distinct roles of dopamine D3 receptors in modulating methamphetamine-induced behavioral sensitization and ultrastructural plasticity in the shell of the nucleus accumbens.

The role of heterodimers formed by histamine H3 receptors and dopamine D1 receptors on the methamphetamine-induced conditioned place preference

Role of Dopamine D3 Receptors in Methamphetamine-Induced Behavioural Sensitization and the Characterization of Dopamine Receptors (D1R–D5R) Gene Expression in the Brain

An Ontogenic Study of Receptor Mechanisms by Which Acute Administration of Low-Doses of Methamphetamine Suppresses DOI-induced 5-Ht2a-receptor Mediated Head-Twitch Response in Mice

Psilocin Suppresses Methamphetamine‐induced Hyperlocomotion and Acquisition of Conditioned Place Preference Via D2R‐mediated ERK Signaling

Effects of Dextromethorphan on Neurite Outgrowth and Marble Burying Behavior

Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment

Efficacy Of Dextromethorphan For The Treatment Of Depression: A Systematic Review Of Preclinical And Clinical Trials

Effects of Low-Doses of Methamphetamine on D-Fenfluramine-induced Head-Twitch Response (HTR) in Mice During Ageing and C-Fos Expression in the Prefrontal Cortex

Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence

Dopamine transporter dysfunction in Han Chinese people with chronic methamphetamine dependence after a short-term abstinence.

Basolateral Amygdala Serotonin 2C Receptor Regulates Emotional Disorder-Related Symptoms Induced by Chronic Methamphetamine Administration

Effect of Chaihu-jia-Longgu-Muli decoction on withdrawal symptoms in rats with methamphetamine-induced conditioned place preference

Knockout of Dopamine D3 Receptor Gene Blocked Methamphetamine-Induced Distinct Changes of Dopaminergic and Glutamatergic Synapse in the Nucleus Accumbens Shell of Mice

N-tert-butoxycarbonyl-methylenedioxymethamphetamine, an methylenedioxymethamphetamine derivative, exhibits rewarding and reinforcing effects by increasing dopamine levels.